During the past decade, Australian Clinical Research Organisation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Australian Clinical Research Organisation" are "Cachexia" (1 trials), "Fatigue" (1 trials), "Influenza" (1 trials) and "NSCLC" (1 trials). Many other conditions were trialed in "Australian Clinical Research Organisation" in a lesser frequency.

Most popular intervention types in "Australian Clinical Research Organisation" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "ALD518" (1 trials), "CSL Limited Influenza Vaccine" (1 trials), "Infusion of 0.9% Saline without ALD518" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Australian Clinical Research Organisation" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Australian Clinical Research Organisation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Australian Clinical Research Organisation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Australian Clinical Research Organisation, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".